Response to "Comments on 'Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study'".

Radiother Oncol

Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou 510060, PR China. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2024.110327DOI Listing

Publication Analysis

Top Keywords

response "comments
4
"comments 'radiotherapy
4
'radiotherapy versus
4
versus concurrent
4
concurrent chemoradiotherapy
4
chemoradiotherapy patients
4
patients stage
4
stage t3n0
4
t3n0 nasopharyngeal
4
nasopharyngeal carcinoma
4

Similar Publications

Dolphin and porpoise detections by the F-POD are not independent: Implications for sympatric species monitoring, Cosentino, Marcolin, Griffiths, Sánchez-Camí, and Tougaard [(2024). JASA Express Lett. 4, 031202] address a significant issue, the reliability of the discrimination of dolphins and porpoises in recordings of their acoustic clicks by F-POD loggers, but unfortunately present a misleading interpretation of the process and results.

View Article and Find Full Text PDF

Complementary and integrative medicine (CIM) encompasses over 400 modalities, according to the World Health Organization (WHO). In 2011, 70% of the European Union's population reported having used CIM at least once, with 25% using it annually. This study examines the engagement, motivations, and satisfaction of users in the French health care system through data from Medoucine, France's largest online platform for complementary therapies.

View Article and Find Full Text PDF

Recently, the Therapeutic Goods Administration (TGA) updated its guidance on cosmetic injectables advertising. The updates confirm that all direct or indirect advertising of cosmetic injectable products, including botulinum toxins or dermal fillers, is prohibited in Australia. While some commentators have lamented these updates, they present no changes to the law.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!